[Federal Register Volume 86, Number 140 (Monday, July 26, 2021)]
[Notices]
[Pages 40055-40057]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15796]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-21-1046; Docket No. CDC-2021-0074]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP) Monitoring Activities. 
Proposed study is designed to collect information about implementation, 
including delivery of screening and follow-up clinical services, and 
outcomes of the NBCCEDP.

DATES: CDC must receive written comments on or before September 24, 
2021.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0074 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP) Monitoring Activities--(OMB Control No. 0920-1046, Exp. 11/
30/2021)--Revision--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    CDC is requesting a Revision of the information collection with the 
OMB Control Number 0920-1046, titled ``National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP) Monitoring Activities.'' In 
the previous OMB approval period, information collection consisted of 
an annual NBCCEDP survey and clinic-level data collection. In the next 
OMB approval period, information collection will consist of a revised 
NBCCEDP survey, revised clinic-level data collection, new quarterly 
program update, new service delivery projection worksheet, and the 
addition of previously approved minimum data elements (MDEs; OMB 
Control No. 0920-0571, Exp. 11/30/2021) to increase efficiency. The 
number of respondents will remain the same and the total estimated 
annualized burden will increase from 683 to 1,216.
    Breast and cervical cancers are prevalent among U.S. women. In 
2017, the U.S. experienced 250,520 new cases and 42,000 deaths as a 
result of breast

[[Page 40056]]

cancer, as well as 12,831 new cases and 4,207 deaths as a result of 
cervical cancer. Evidence shows that deaths from both breast and 
cervical cancers can be avoided by increasing screening services--
mammography and PAP tests--among women. However, screening is typically 
underutilized among women who are under- or uninsured, have no regular 
source of healthcare, or who recently immigrated to the U.S. As a 
longstanding priority within chronic disease prevention, CDC focuses on 
increasing access to these cancer screenings, particularly among women 
who may be at increased risk.
    To improve access to cancer screening, Congress passed the Breast 
and Cervical Cancer Mortality Prevention Act of 1990 (Pub. L. 106-354), 
which directed CDC to create the National Breast and Cervical Cancer 
Early Detection Program (NBCCEDP). The NBCCEDP currently provides 
funding to 70 awardees under ``Cancer Prevention and Control Programs 
for State, Territorial, and Tribal Organizations (DP17-1701).'' NBCCEDP 
awardees include states or their bona fide agents; U.S. territories; 
and tribes or tribal organizations. The purpose of NBCCEDP is to 
increase breast and cervical cancer screening rates among women 
residing within defined geographical locations (as determined by the 
funded program) who are at or below 250% of the federal poverty level; 
aged 40-64 years for breast cancer services, and aged 21-64 years for 
cervical cancer services; and under- or uninsured.
    In 2022, CDC will issue a new Notice of Funding Opportunity (DP22-
2202) to continue this mission. Consistent with programmatic changes, 
the information collection plan has also been redesigned to update 
existing, and add new data collection instruments, and to integrate the 
previously approved MDEs into this single approval package to increase 
efficiency of information collection for the NBCCEDP. This revised 
information collection will allow CDC to provide routine monitoring 
feedback to awardees based on their data submissions, tailor technical 
assistance (TA) as needed, support program planning, and assess program 
outcomes.
    CDC proposes five forms of information collection. First, the 
NBCCEDP survey will be submitted to CDC annually and collects 
information to monitor awardees' TA needs, external funding sources, 
partnerships, EBI implementation, and COVID-19 impact. Minor revisions 
to survey questions and formatting reflect the program under DP22-2202. 
Second, clinic-level data will be submitted to CDC at baseline and 
annually for all partnering health system clinic sites--an estimated 
six clinics per awardee for breast cancer data and six clinics per 
awardee for cervical cancer data. Clinic-level data allow CDC to assess 
health system, clinic, and patient population characteristics; 
monitoring and quality improvement activities; EBI implementation; and 
baseline or annual screening rates. Minor revisions were made to 
variable wording, formatting (e.g., split or combined variables), and 
response options to improve data quality. Third, quarterly program 
updates will be submitted to CDC four times per year to monitor award 
spending, service delivery, staff vacancies, program challenges and 
successes, and TA needs. This is a new information collection. Fourth, 
the service delivery projection worksheet will be submitted to CDC 
annually to provide an estimate of the number of women served for 
breast and cervical cancer. Fifth, the minimum data elements (MDEs) 
will be submitted to CDC twice per year to monitor patient 
demographics; breast and cervical cancer screening, diagnosis, and 
treatment; timeliness of services; and patient navigation. This 
information collection was previously approved (OMB No. 0920-0571, exp. 
03/30/2022) and incorporated into this approval package for increased 
efficiency for NBCCEDP information collection efforts.
    The proposed information collections will allow CDC to gauge 
progress in meeting NBCCEDP program goals and monitor implementation 
activities, evaluate outcomes, and identify awardee TA needs. In 
addition, findings will inform program improvement and help identify 
successful activities that need to be maintained, replicated, or 
expanded.
    OMB approval is requested for three years. CDC requests approval 
for an estimated 1,216 annual burden hours. Participation is required 
for NBCCEDP awardees. There are no costs to respondents other than 
their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Awardees..............  Annual NBCCEDP                70               1           45/60              53
                                 Survey.
                                NBCCEDP Clinic-               70               6           45/60             315
                                 level
                                 Information
                                 Collection
                                 Instrument--Bre
                                 ast.
                                NBCCEDP Clinic-               70               6           45/60             315
                                 level
                                 Information
                                 Collection
                                 Instrument--Cer
                                 vical.
                                Quarterly                     70               4           32/60             149
                                 Program Update.
                                Service Delivery              70               1           29/60              34
                                 Projection
                                 Worksheet.
                                MDEs............              70               2          150/60             350
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           1,216
----------------------------------------------------------------------------------------------------------------



[[Page 40057]]

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-15796 Filed 7-23-21; 8:45 am]
BILLING CODE 4163-18-P